CTI BIOPHARMA CORP
Total Trades
37
Buys
1
Sells
17
Largest Trade
$1M+
Insiders
5
Institutional Funds
1
Inst. Value
$100K–$500K
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Craig Adam R | President and CEO | EXERCISE | $50K–$100K | 85K | $0.84 | Jan 26, 2023 |
| Craig Adam R | President and CEO | SELL | $500K+ | 85K | $6.00 | Jan 26, 2023 |
| Fong James K | EVP & Chief Commer… | EXERCISE | $50K–$100K | 100K | $0.95 | Jan 26, 2023 |
| Fong James K | EVP & Chief Commer… | SELL | $500K+ | 100K | $6.00 | Jan 26, 2023 |
| Craig Adam R | President and CEO | SELL | $500K+ | 116K | $6.01 | Jan 4, 2023 |
| Craig Adam R | President and CEO | GRANT | $1K–$15K | 2K | $5.11 | Jan 4, 2023 |
| Craig Adam R | President and CEO | EXERCISE | $50K–$100K | 116K | $0.84 | Jan 4, 2023 |
| KIRSKE DAVID | CFO | EXERCISE | $50K–$100K | 54K | $0.95 | Jan 3, 2023 |
| KIRSKE DAVID | CFO | GRANT | $1K–$15K | 214 | $5.11 | Jan 3, 2023 |
| KIRSKE DAVID | CFO | SELL | $100K–$500K | 54K | $6.01 | Jan 3, 2023 |
| Craig Adam R | President and CEO | EXERCISE | $100K–$500K | 242K | $0.84 | Nov 14, 2022 |
| Craig Adam R | President and CEO | SELL | $1M+ | 242K | $6.00 | Nov 14, 2022 |
| Metzger Michael A | Director | SELL | $500K+ | 92K | $5.58 | Nov 10, 2022 |
| Metzger Michael A | Director | EXERCISE | $50K–$100K | 92K | $0.95 | Nov 10, 2022 |
| KIRSKE DAVID | CFO | SELL | $1K–$15K | 2K | $6.26 | Oct 6, 2022 |
| KIRSKE DAVID | CFO | EXERCISE | $1K–$15K | 2K | $0.95 | Oct 6, 2022 |
| KIRSKE DAVID | CFO | EXERCISE | $100K–$500K | 141K | $0.95 | Oct 3, 2022 |
| KIRSKE DAVID | CFO | SELL | $500K+ | 141K | $6.05 | Oct 3, 2022 |
| KIRSKE DAVID | CFO | SELL | $100K–$500K | 23K | $6.02 | Sep 20, 2022 |
| KIRSKE DAVID | CFO | GRANT | $15K–$50K | 10K | $2.12 | Sep 20, 2022 |
| KIRSKE DAVID | CFO | EXERCISE | $15K–$50K | 23K | $0.95 | Sep 20, 2022 |
| Craig Adam R | President and CEO | SELL | $1M+ | 242K | $6.43 | Sep 14, 2022 |
| Craig Adam R | President and CEO | EXERCISE | $100K–$500K | 242K | $0.84 | Sep 14, 2022 |
| Craig Adam R | President and CEO | BUY | $15K–$50K | 5K | $5.50 | Aug 16, 2022 |
| BVF PARTNERS L P/IL | Director | SELL | $1M+ | 8.5M | $6.12 | Aug 11, 2022 |
| Metzger Michael A | Director | SELL | $100K–$500K | 20K | $6.51 | Jul 11, 2022 |
| Metzger Michael A | Director | SELL | $500K+ | 92K | $6.08 | Jul 7, 2022 |
| Metzger Michael A | Director | EXERCISE | $50K–$100K | 92K | $0.84 | Jul 7, 2022 |
| Craig Adam R | President and CEO | GRANT | $1K–$15K | 6K | $2.12 | Jul 6, 2022 |
| Craig Adam R | President and CEO | SELL | $100K–$500K | 72K | $6.03 | Jul 6, 2022 |
| Craig Adam R | President and CEO | EXERCISE | $50K–$100K | 72K | $0.84 | Jul 6, 2022 |
| KIRSKE DAVID | CFO | SELL | $100K–$500K | 60K | $6.21 | Jun 17, 2022 |
| KIRSKE DAVID | CFO | EXERCISE | $100K–$500K | 60K | $2.92 | Jun 17, 2022 |
| KIRSKE DAVID | CFO | SELL | $50K–$100K | 10K | $5.50 | Jun 16, 2022 |
| KIRSKE DAVID | CFO | EXERCISE | $1K–$15K | 10K | $0.95 | Jun 16, 2022 |
| Craig Adam R | President and CEO | EXERCISE | $50K–$100K | 72K | $0.84 | Jun 3, 2022 |
| Craig Adam R | President and CEO | SELL | $100K–$500K | 72K | $6.00 | Jun 3, 2022 |
Institutional Ownership
13F filings as of Mar 31, 2023 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEW YORK STATE COMMON RETIREMENT FUND | 48K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
BIOTECHNOLOGY VALUE FUND, L.P.
SC 13D/A · Jun 28, 2023
0.0%
0 shares
Stonepine Capital Management, LLC
SC 13G · Apr 14, 2023
5.3%
7.0M shares
SC 13G · Mar 24, 2023
5.3%
7.0M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 13, 2023
3.9%
4.9M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 3, 2023
12.6%
0 shares
SC 13G · Feb 3, 2023
5.6%
7.1M shares
SC 13G/A · Jan 9, 2023
3.9%
5.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Oct 11, 2022
12.0%
0 shares
BIOTECHNOLOGY VALUE FUND, L.P.
SC 13D/A · Aug 11, 2022
14.4%
19.9M shares
Growth Equity Opportunities Fund V, LLC
SC 13D/A · Jun 17, 2022
8.8%
9.6M shares
SC 13G · Jun 13, 2022
5.5%
5.9M shares
SC 13G/A · Feb 14, 2022
2.3%
2.2M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 12, 2022
10.0%
9.8M shares